Separately, Liberum Capital reiterated a buy rating and issued a GBX 725 ($9.47) price target on shares of Eco Animal Health Group in a research report on Monday, July 2nd.
LON:EAH traded up GBX 5 ($0.07) during trading hours on Friday, reaching GBX 400 ($5.23). The company had a trading volume of 30,957 shares, compared to its average volume of 39,512. Eco Animal Health Group has a one year low of GBX 485 ($6.34) and a one year high of GBX 680 ($8.89).
In other Eco Animal Health Group news, insider Anthony Paul Rawlinson sold 60,000 shares of the company’s stock in a transaction on Tuesday, August 28th. The stock was sold at an average price of GBX 500 ($6.53), for a total value of £300,000 ($392,003.14).
About Eco Animal Health Group
ECO Animal Health Group plc develops and markets pharmaceutical products for animals worldwide. The company offers Aivlosin, a macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry. It also provides generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.
Featured Article: How is inflation measured?
Receive News & Ratings for Eco Animal Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eco Animal Health Group and related companies with MarketBeat.com's FREE daily email newsletter.